2020's Information

2020/11/02

Chinese Journal of Tuberculosis and Respiratory Diseases recommended the use of Pirfenidone as an anti-fibrosis therapy for COVID-19 patients in China

2020/08/14

Notice of land acquisition by Beijing Continent Pharmaceutical Co., Ltd.

2020/04/30

Selected 140th in the ranking of Financial Times High-Growth Companies Asia-Pacific 2020

2020/03/24

A study to evaluate the efficacy and safety of Pirfenidone for the novel Coronavirus infection 2

2020/03/17

Update on Coronavirus epidemic

2020/03/10

Supporting a study to evaluate the efficacy and safety of Pirfenidone

2020/03/02

Fourth update on Coronavirus epidemic in China

2020/02/12

Social contribution for coronavirus epidemic in China

2020/02/12

Third update on Coronavirus epidemic in China

2020/01/31

Update on Coronavirus epidemic in China